More advanced therapies are being aimed at cancer

More advanced therapies are being aimed at cancer

New research shows a sharp escalation in the weapons race against cancer. Scientists are reporting success with several high-tech approaches long dreamed of but not possible or proven to work until now.

Source: news.yahoo.com

Follow-up Avastin shown to benefit colon cancer patients

CHICAGO (Reuters) - Colorectal cancer patients treated with a follow-up round of Avastin fare better than those given chemotherapy alone after their disease has worsened, according to results of a large clinical trial. Avastin, sold by Roche, is approved as a first-line or second-line treatment for colorectal cancer, but not for both. Sales of the drug, also known as bevacizumab, totaled $5.3 billion Swiss francs ($5.5 billion) last year. ... Courtesy of Yahoo News

Study: 'Smart bomb' drug attacks breast cancer

Doctors have successfully dropped the first "smart bomb" on breast cancer, using a drug to deliver a toxic payload to tumor cells while leaving healthy ones alone.

Get the complete story

Avastin delays progression of ovarian cancer

CHICAGO (Reuters) - Adding cancer drug Avastin to standard chemotherapy doubled the length of time a certain group of advanced ovarian cancer patients lived without their disease getting worse, according to results of a clinical trial. The study involved 361 women whose cancer had stopped responding to traditional platinum-based chemotherapy. After a median follow-up of 13.5 months, 75 percent of Avastin patients had a recurrence of cancer, compared to 91 percent of those who received chemotherapy alone. The median time to disease progression or death was 6. ... Credit of the story

Study: Hormone pill slows prostate cancer's growth

A hormone-blocking pill approved last year for some men with advanced prostate cancer now also seems to help a wider group of men who were given it sooner in the course of treating their disease.

Click here to read the rest